Literature DB >> 9430652

Modulation of the intracellular stability and toxicity of diphtheria toxin through degradation by the N-end rule pathway.

P O Falnes1, S Olsnes.   

Abstract

The enzymatically active A-fragment of diphtheria toxin enters the cytosol of sensitive cells where it inhibits protein synthesis by inactivating elongation factor 2 (EF-2). We have constructed a number of diphtheria toxin mutants that are degraded by the N-end rule pathway in Vero cells, and that display a wide range of intracellular stabilities. The degradation could be inhibited by the proteasome inhibitor lactacystin, indicating that the proteasome is responsible for N-end rule-mediated degradation in mammalian cells. Previously, the N-end rule has been investigated by studying the co-translational degradation of intracellularly expressed beta-galactosidase. Our work shows that a mature protein entering the cytosol from the exterior can also be degraded by the N-end rule pathway with a similar, but not identical specificity to that previously found. We found a correlation between the intracellular stability of the mutants and their toxic effect on cells, thus demonstrating a novel manner of modulating the toxicity of a protein toxin. The data also indicate that the inactivation of EF-2 is the rate-limiting step in the intoxication process.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9430652      PMCID: PMC1170411          DOI: 10.1093/emboj/17.2.615

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  58 in total

1.  Using ubiquitin to follow the metabolic fate of a protein.

Authors:  F Lévy; N Johnsson; T Rümenapf; A Varshavsky
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

2.  Role of arginine-tRNA in protein degradation by the ubiquitin pathway.

Authors:  S Ferber; A Ciechanover
Journal:  Nature       Date:  1987 Apr 23-29       Impact factor: 49.962

3.  Low pH-induced release of diphtheria toxin A-fragment in Vero cells. Biochemical evidence for transfer to the cytosol.

Authors:  J O Moskaug; K Sandvig; S Olsnes
Journal:  J Biol Chem       Date:  1988-02-15       Impact factor: 5.157

Review 4.  Cotranslational processing and protein turnover in eukaryotic cells.

Authors:  S M Arfin; R A Bradshaw
Journal:  Biochemistry       Date:  1988-10-18       Impact factor: 3.162

5.  Nucleotide sequence of the Shiga-like toxin genes of Escherichia coli.

Authors:  S B Calderwood; F Auclair; A Donohue-Rolfe; G T Keusch; J J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

6.  Specificity of binding of NH2-terminal residue of proteins to ubiquitin-protein ligase. Use of amino acid derivatives to characterize specific binding sites.

Authors:  Y Reiss; D Kaim; A Hershko
Journal:  J Biol Chem       Date:  1988-02-25       Impact factor: 5.157

Review 7.  Selective protein degradation: a journey's end within the proteasome.

Authors:  S Jentsch; S Schlenker
Journal:  Cell       Date:  1995-09-22       Impact factor: 41.582

8.  CDNA cloning of p112, the largest regulatory subunit of the human 26s proteasome, and functional analysis of its yeast homologue, sen3p.

Authors:  K Yokota; S Kagawa; Y Shimizu; H Akioka; C Tsurumi; C Noda; M Fujimuro; H Yokosawa; T Fujiwara; E Takahashi; M Ohba; M Yamasaki; G N DeMartino; C A Slaughter; A Toh-e; K Tanaka
Journal:  Mol Biol Cell       Date:  1996-06       Impact factor: 4.138

9.  Cloning and sequencing of the genes for Shiga toxin from Shigella dysenteriae type 1.

Authors:  N A Strockbine; M P Jackson; L M Sung; R K Holmes; A D O'Brien
Journal:  J Bacteriol       Date:  1988-03       Impact factor: 3.490

10.  Yeast N-terminal amidase. A new enzyme and component of the N-end rule pathway.

Authors:  R T Baker; A Varshavsky
Journal:  J Biol Chem       Date:  1995-05-19       Impact factor: 5.157

View more
  12 in total

1.  Toxins that are activated by HIV type-1 protease through removal of a signal for degradation by the N-end-rule pathway.

Authors:  P O Falnes; R Welker; H G Kräusslich; S Olsnes
Journal:  Biochem J       Date:  1999-10-01       Impact factor: 3.857

Review 2.  The N-end rule pathway and regulation by proteolysis.

Authors:  Alexander Varshavsky
Journal:  Protein Sci       Date:  2011-08       Impact factor: 6.725

Review 3.  Designing immunotoxins for cancer therapy.

Authors:  Christopher A Pennell; Heidi A Erickson
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

4.  Sensitivity of cancer cells to truncated diphtheria toxin.

Authors:  Yi Zhang; Wendy Schulte; Desmond Pink; Kyle Phipps; Andries Zijlstra; John D Lewis; David Morton Waisman
Journal:  PLoS One       Date:  2010-05-05       Impact factor: 3.240

5.  Processing of Pseudomonas aeruginosa exotoxin A is dispensable for cell intoxication.

Authors:  Juliette Morlon-Guyot; Jocelyn Méré; Anne Bonhoure; Bruno Beaumelle
Journal:  Infect Immun       Date:  2009-04-20       Impact factor: 3.609

Review 6.  Toxin-based therapeutic approaches.

Authors:  Assaf Shapira; Itai Benhar
Journal:  Toxins (Basel)       Date:  2010-10-28       Impact factor: 4.546

Review 7.  Channel-forming bacterial toxins in biosensing and macromolecule delivery.

Authors:  Philip A Gurnev; Ekaterina M Nestorovich
Journal:  Toxins (Basel)       Date:  2014-08-21       Impact factor: 4.546

8.  Anthrax toxin-mediated delivery of the Pseudomonas exotoxin A enzymatic domain to the cytosol of tumor cells via cleavable ubiquitin fusions.

Authors:  Christopher Bachran; Thomas Morley; Suzanne Abdelazim; Rasem J Fattah; Shihui Liu; Stephen H Leppla
Journal:  mBio       Date:  2013-04-30       Impact factor: 7.786

9.  Role of N-terminal amino acids in the potency of anthrax lethal factor.

Authors:  Pradeep K Gupta; Mahtab Moayeri; Devorah Crown; Rasem J Fattah; Stephen H Leppla
Journal:  PLoS One       Date:  2008-09-03       Impact factor: 3.240

10.  A d-Amino Acid at the N-Terminus of a Protein Abrogates Its Degradation by the N-End Rule Pathway.

Authors:  Amy E Rabideau; Bradley L Pentelute
Journal:  ACS Cent Sci       Date:  2015-11-11       Impact factor: 14.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.